Tofacitinib + Methotrexate: 2-Year Clinical, Radiographic & Safety Outcomes
Upadacitinib Monotherapy Effective in Refractory Rheumatoid Arthritis
FDA Approves Risankizumab, Adds Stronger Warning to Sleep Medications
British Columbia Will Be First Canadian Province to Switch Patients to Biosimilars
WHO Drug Pricing Talks May Fail to End Secrecy, Activists Fear
U.S. Supreme Court Tosses Ruling Against Merck on Fosamax Osteoporosis Drug
Common Characteristics in RA Patients Who Don’t Respond to Biologics
Rheumatology Drugs at a Glance, Part 2: Psoriasis
Trump Slams Drugmakers, Vows to Let U.S. States Buy Cheaper Medicines Abroad
- 1
- 2
- 3
- …
- 93
- Next Page »